IBB vs IHI: Holdings Overlap & Returns

Over the year to Nov 13, 2026, IBB returned +30.4% to IHI's −7.4%; 0% of their weight is in the same names.

Return gap
+37.8 pts1 year to Nov 13, 2026: IBB ahead, total return
Fee gap
0.07 ptsA year: IBB 0.44%, IHI 0.37%, per filings dated Jul 27, 2026
Overlap
0%Share of the two books held in common, holdings dated Nov 12, 2026
Net flow
−$50m / +$76mIBB / IHI, Oct 13, 2026 to Nov 12, 2026, daily basis
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
IBB and IHI · 1 year

Growth of 100

IBB +30.4%IHI −7.4%
Growth of 100 in IBB and IHI over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. IBB ends at 130.4 (+30.4%), IHI at 92.6 (−7.4%).

IBB +30.4%, IHI −7.4%: IBB +37.8 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Client brief:

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

IBB and IHI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag the order size

Cost to trade

Hypothetical. A $10,000 order in IBB costs about $2.00 one way and $4.00 in and out, at a median spread of 0.04%. The 0.04% spread is IBB’s 30-day median, from iShares (fund page).

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in IBB for 10 years at 0.44% a year costs about $730 in fees and lost growth; IHI at 0.37% would cost $615. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

IBB · 1 year to Nov 13, 202657% of its weight is outside the S&P 500
57% of its weight is outside the S&P 50043% of IBB's weight is in S&P 500 companies and 57% is outside the index. Holdings as of Nov 12, 2026.43%57%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · top ten 52% of the fund · 245 holdings as published by its issuer for Nov 12, 2026 · Nasdaq-100: 33% in57% of its weight is outside the S&P 50043% of IBB's weight is in S&P 500 companies and 57% is outside the index. Holdings as of Nov 12, 2026.43%57%in the S&P 500outside the S&P 500active share 99% · Nasdaq-100: 33% in

43% of IBB's weight is in S&P 500 companies and 57% is outside the index. Holdings as of Nov 12, 2026.

IHI · 1 year to Nov 13, 202612% of its weight is outside the S&P 500
12% of its weight is outside the S&P 50089% of IHI's weight is in S&P 500 companies and 12% is outside the index. Holdings as of Nov 12, 2026.89%12%of its weight in S&P 500 companiesoutsideactive share 99% · top ten 76% of the fund · 51 holdings as published by its issuer for Nov 12, 2026 · Nasdaq-100: 28% in12% of its weight is outside the S&P 50089% of IHI's weight is in S&P 500 companies and 12% is outside the index. Holdings as of Nov 12, 2026.89%12%of its weight in S&P 500 companies12% of its weight outside the S&P 500active share 99% · Nasdaq-100: 28% in

89% of IHI's weight is in S&P 500 companies and 12% is outside the index. Holdings as of Nov 12, 2026.

Key numbers

IBB in the S&P 500
42.6%
IHI in the S&P 500
88.5%
IBB total return, 1 year
+30.4%
IHI total return, 1 year
−7.4%

IHI costs 0.07 points a year less; their one-year returns differ by 37.8 points; IBB is 2.8 times larger.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year+30.4%−7.4%
Below its all-time high11.5%, high on Sep 8, 2021
What it tracksBiotechTherapeutics and medical devices
Expense ratio0.44%0.37%
Net assets, as of Nov 12, 2026$11.1bn$4.0bn
Holdings in common0%

The numbers behind it

Net assets: $11.1bn on Nov 12, 2026 for iShares Biotechnology ETF, and $4.1bn on Nov 13, 2026 for iShares U.S. Medical Devices ETF.

Holdings in common uses holdings dated Nov 12, 2026.

What they share

By the books each fund has filed, IBB and IHI hold 0% of their money in the same securities at the same weight. Holdings dated Nov 12, 2026.

0half (50%)100%

half

0% in common

Held in common

Show all 2 holdings
NOVOCURE0.08%0.16%
E-MINI HEALTH CARE SECTOR DEC 260.00%0.00%

Only in IBB

Show all 8 holdings
GILEAD SCIENCES8.96%
AMGEN INC8.48%
VERTEX PHARMACEUTICALS7.78%
REGENERON PHARMACEUTICALS6.51%
MODERNA5.84%
ARGENX SE ADR3.77%
NATERA3.00%
BIOGEN2.54%

Only in IHI

Show all 8 holdings
ABBOTT LABORATORIES17.27%
INTUITIVE SURGICAL14.46%
MEDTRONIC PLC11.51%
IDEXX LABORATORIES5.48%
EDWARDS LIFESCIENCES4.96%
BECTON DICKINSON AND CO4.85%
GE HEALTHCARE TECHNOLOGIES4.63%
STRYKER4.59%

Side by side

Open the table
FundiShares Biotechnology ETF · Holds 245 stocks in biotech, 43% of its weight in S&P 500 companiesiShares U.S. Medical Devices ETF · Holds 51 stocks in therapeutics and medical devices, 88% of its weight in S&P 500 companies
IssueriSharesiShares
ThemeBiotechTherapeutics and medical devices
In the S&P 50042.6%88.5%
Active share vs the S&P 50099.0%98.7%
In the Nasdaq-10033.2%28.4%
Holdings24551
Top ten, share of the fund51.6%76.0%
Expense ratio0.44%0.37%
Fee for the differing part0.44%0.37%
Total return, 1 year+30.4%−7.4%
vs its benchmarknot measurednot measured
Below its high−3.9%−11.5%
Net assets, IBB as of Nov 12, 2026 and IHI as of Nov 13, 2026$11.1bn$4.1bn

As of Nov 13, 2026. Source: ETFIQ.

Window by window

Open the table
3 months+7.2%+4.2%
6 months+27.4%+20.1%
1 year+30.4%−7.4%
3 years+81.5%+23.4%
Since launch (Not the same days: IBB Feb 2001 · IHI May 2006)+543.4%+658.0%

From Jan 2010 to Nov 2026, IBB returned more: +688.1% to +585.6%. IHI swung less: 18.2% to 22.6%. IHI fell less at its worst: −32.7% to −37.5%.

Jan 15, 2010 to Nov 13, 2026 · 878 weekly returns · 9 measures

Full scorecard

Open the table
Total return+688.1%+585.6%IBBPrice change plus distributions, reinvested.
Annualized+13.0%+12.1%IBB (slight)Total return as a yearly rate.
Price return+657.0%+534.9%IBBPrice change alone, distributions left out.
Volatility22.6%18.2%IHISpread of weekly returns, annualized. Lower is steadier.
Downside deviation15.5%12.5%IHILike volatility, counting only weeks below the Treasury bill rate.
Max drawdown−37.5%−32.7%IHIDeepest fall from a high to the low after it.
Sharpe0.590.63IHI (slight)Return above Treasury bills per unit of volatility.
Sortino0.860.92IHI (slight)Return above Treasury bills per unit of downside deviation.
Calmar0.350.37IHI (slight)Annualized return divided by the max drawdown.
More

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 878 weekly returns. Cash rate: the 13-week Treasury bill.

About IBB

By weight, 43% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 52% of the fund across 245 positions, as published by its issuer for Nov 12, 2026.

More

Over the year to Nov 13, 2026 the fund returned +30.4% with distributions reinvested.

About IHI

By weight, 88% of IHI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 76% of the fund across 51 positions, as published by its issuer for Nov 12, 2026.

More

Over the year to Nov 13, 2026 the fund returned −7.4% with distributions reinvested. It sits 11.5% below its all-time high of Sep 8, 2021.

0% of the two portfolios are the same securities at the same weight.

Questions people ask

Do IBB and IHI hold the same stocks?

By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, IBB or IHI?

IBB has 43% of its weight in S&P 500 names and IHI has 88%, so IBB differs more from the index.

Which is cheaper, IBB or IHI?

IBB charges 0.44% a year and IHI charges 0.37%, so IHI is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, IBB against IHI, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ibb-vs-ihi

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.